Nearly a thousand pharmacists of Spain and Latin America will discuss the future of pharmaceutical care in Seville.
Nearly a thousand pharmacists of Spain and Latin America will discuss the future of pharmaceutical care in Seville.
Read MoreGeneral |
Nearly a thousand pharmacists of Spain and Latin America will discuss the future of pharmaceutical care in Seville.
Read MoreGeneral |
la Fundación Jesús Serra and the Cardiovascular Research Foundation celebrated the day world of the heart.
Jesús Serra Foundation promotes the prevention and treatment of cardiovascular disease in a conference held yesterday at the headquarters of the ICCC.
Barcelona, September 2009.- Recognized experts in cardiology and more than 100 guests at the Symposium attendees gathered yesterday in Barcelona on the occasion of the world heart day “ Cardiovascular Health: the cell, the patient, to the society ” which has been organized and sponsored by the Fundación Jesús Serrabelonging to the Group Catalana Occidente, in collaboration with the Institut Català of cardiovascular Sciences (ICCC), the Fundació d ’ Cardiovascular Research and medicine solidarity Foundation. This Act has as object the prevention of major cardiovascular diseases that affect the Spanish population-influencing.
The program of the day, in which speakers as moderators Dr. Manté and Dr. Bayés de Luna, has been with the paper “ risk factors in cardiovascular diseases ” carried out by Dr. Josep Guindo. Then the paper with the title “ physical exercise and cardiovascular health ” has been given by the expert in cardiology, Dr. Roberto Elosua. The cycle of conferences has concluded with the presentation of the DRA. Lina Badimon, Director of the ICCC on Subclinical Atherosclerosis and clinical manifestation of cardiovascular disease, after which the Doctor Moon Bayés has presented to society the medical foundation of solidarity.
During the event the President of the Jesús Serra Foundation, Federico Halpern has made delivery in cardiology clinic to Diego Goldwasser Serra Jesus Foundation predoctoral PhD students scholarship and fellowship Postdoctoral Foundation Jesus Serra in Cardiovascular Research to José MarÃa Belloso. Federico Halpern has stated that “ have a Chair of cardiovascular research of this prestige are proud as a foundation and as a company, but above all allows us to make progress in the prevention of such risks, a priority for us ”.
During the day has been the signing ceremony of the renewal of the cooperation agreement between the Jesús Serra Foundation and the Foundation for Cardiovascular Research for the next 3 years. Through this initiative, Jesús Serra Foundation offers its support to the study of the treatment and prevention of major diseases related to the heart through its Chair in Cardiovascular Research, sponsored since 1993 in collaboration with the Faculty of Medicine of the University autonomous of Barcelona (UAB) and the Hospital de la Santa Creu i Sant Pau.
On the Fundación Jesús Serra
Named since October 2006, it was created by Catalana Occidente Group 9 years with a view to channelling large philanthropic, cultural and social activity that had been developed historically. Recently, it was called Jesús Serra Foundation in memory and recognition of the late founder of the group, Jesús Serra Santamans, strong supporter of the family business, as well as promoter of sports and cultural entities that has earned it numerous awards for his work as a businessman and patron.
About the Cardiovascular Research Foundation
The Foundation’s Research Cardiovascular of the Hospital of la Santa Creu i Sant Pau was constituted on January 23, 1992 in order to promote, disseminate and improve knowledge of cardiology at all levels and with the priority objective of enhancing cardiovascular research, particularly related to ischemic heart disease. The activities developed by the Foundation are related to the publication of texts on cardiology, the creation of a library specialized on the subject, the Organization of symposia, conferences and round tables with prestigious professionals, collaboration with other entities for the purpose of exchanging knowledge and the sponsorship of the cardiac medicine teachingdissemination and research new theories and techniques.
On the medical solidarity Foundation
The medical foundation of solidarity, founded in 2005, carries out projects of cooperation to combat cardiovascular diseases with the aim of training professionals through online education, preventing the risk factors for cardiovascular disease and provide technological assistance to other countries. In his three years of life, it has carried out projects in Mongolia, Mexico, Central America and El Caribbean, Bolivia, Paraguay, China and Mozambique, getting so thousands of doctors have specialised without having to leave their homes.
Read More
General |
between 25-40% of the population has an episode of anxiety throughout his life.
VIII meeting annual of the society Basque-Navarre of Psychiatry.
• Anxiety disorders involve a huge social burden of disability and social cost
• 70-80% of young people with anti-social behaviour, suicide attempts, violent behaviors or drug abuse disorders suffer from disorders limit personality.
• Linked to family and work stress and anxiety are more concern to the scientific community.
• Becoming unemployed, the man enters in a free and competitive market for which it is not ready. In these cases it is usual that the male fall into a depression, suicide attempt, consumption of alcohol, violence and myocardial infarctions.
Bilbao, September 2009.- Stress is an experience of psychological instability as a response to external environmental factors. This disease is a source of pathology and produces a short, medium and long term impact. In addition, you can damage the brain at the molecular level and from there, extend their damage to the rest of the body. This is the starting point from which José Luis Carrasco, head of section of the service of Psychiatry and director of the Hospital ClÃnico San Carlos personality disorders unit, performs an analysis on the relationship of this with affection and the different types of personality of the individual.
This complex interplay is the breeding ground of borderline personality disorder, “ a pathology that occurs in 70-80% of young people with antisocial behaviors, suicide attempts, violent behaviors or substance abuse disorders. The origin of it is in internal dysfunctions of the affective and emotional balance, and how to integrate in an appropriate manner the experiences and information that is perceived in the environment, which ultimately can be defined as an emotional immaturity and relationship. These shortcomings lead to a loss of self-control, as well as the own sense of identity. These internal anomalies are the keys of the disorder and the aim to solve for the treatments that you pretend to be effective ”.
Anxiety disorders are psychiatric illness more prevalent among the general population. Indeed, between 25-40% of the population has an episode of anxiety throughout his life. Anxiety and stress appear as two sides of the same coin. “ Anxiety is the psychological aspect of stress and it is the somatic aspect, the biological side of anxiety. Typically, anxiety and/or stress allow the individual to interact with their environment, but when they become pathological can generate the individual suffering, disability to cope with everyday life and an increase in the risk of suicide and fall into addiction. In this regard, stress and anxiety linked to family and work are those that concern most ”, said José Luis Carrasco.
In the words of the expert, “ anxiety disorders involve a huge social burden in terms of disability and social costs, due inter alia to usually appear early (in adolescence), they are very persistent, they produce much suffering, demand an important social-health care, cause frequent off work, etc. ”
this issue in keeping with one of the major concerns of our time: the crisis. José Luis Carrasco understands that “ the crisis syndrome affects all branches of medicine, after various symptoms underlying anxiety and distress, whose origin is the uncertainty about the future ”.
The specialist distinguishes between “ two types of conditions. On the one hand of the individual who has not yet lost their jobs and is located in a more normal situation, whose main problems are dizziness, headaches, lack of sleep or appetite, and pain. On the other hand, are affected directly by the crisis, either by have lost work either because they are in a critical situation. In this case there is a basis of hopelessness that leads to symptoms of depression, despondency, tiredness or lack of interest ”.
Another issue the less funny is that this “ syndrome of the crisis ” affects more men than women. Some recent studies “ have shown that women and men react very differently to stressful situations and against him than previously thought, women are better prepared to deal with great social changes that are very stressful ”. The explanation for this is based on the personal reality of men, according to José Luis Carrasco. “ Becoming unemployed, comes in a free and competitive market and, in many cases, is not ready for that, it is unable to fight, having initiative or set up a small working. In these cases it is usual that the male fall into a depression, suicide attempt, consumption of alcohol, violence and myocardial infarctions ”.
Read More
General |
nutrition in cancer patient and technique elected VMAT, two of the innovations of the XV Congress national of the Lord.
On October 6 kicks off the XV Congress national of the society Spanish of Oncology Radioterapica in Castellón. more than 500 specialists will participate in different conferences and symposia.
Madrid, September 2009.- the Spanish society of Oncology will bring together more than 500 specialists in its 15th National Congress.
The novelty of this edition will be the exhibition of the latest news and clinical evidence regarding the clinical benefit that today provides nutritional treatment for the cancer patient.
Radiation oncologists, experts in the field, explain the causes of malnutrition in patients suffering from the disease, as well as the effectiveness of good nutrition and the importance of specific nutritional supplements to cancer.
This Symposium will also, with the presence of a nurse expert in Oncology, which will give his views on the importance of the oncology nursing in monitoring and treatment of patients.
Another of the themes to be highlighted is the elected VMAT, developed technique to drastically reduce time the endocurietherapy cancer treatment and remove traditional constraints, achieving at the same time, deliver the possible minimum dose to the patient.
This technique uses a collimator only multilaminas and a control system with parameters of treatment of great flexibility which allows greater freedom to treat the patients.
About 500 people between medical specialists in Oncology, nurses, technicians in radiotherapy, physicists and psychologists will meet in this meeting which closed its doors on October 9.
About the Lord
Under the name Sociedad Española de OncologÃa Radioterápica (Mr), refers to the Association of private law, of scientific character, without profit or political purpose of unlimited duration, which brings together all the Optional Spanish or foreign, who duly request, and whose work is primarily developed in the treatment of neoplastic diseases with ionizing radiation.
The scope of the Lord covers branches of the Clinical Oncology that specifically relate to radiotherapy; Oncology; Radiobiology; Radiophysics.
Read More
General |
the intensive early rheumatoid arthritis treatment can halt the progression of the disease.
On 1 October is celebrated the day national of arthritis Rheumatoid.
-The Spanish society of Rheumatology (be) has developed a consensus on biological therapies in rheumatoid arthritis that updated the guidelines before this disease with these innovative drugs
-the combination of methotrexate with biological agents such as the anti-TNF (tumour necrosis factor inhibitors) since the earlier possible are the most desirable treatment
-present There are no data to suggest that an anti-TNF is superior to another, so the choice depends on both the criterion of the doctor and the particular circumstances of the patient
-the complete healing of rheumatoid arthritis is an utopia at the present time. On the other hand, only 40-50% of patients achieved remission of the disease
Madrid, September 2009.- rheumatoid arthritis cure is today still a utopia despite the strides that recent years have taken place in the treatment of this disease. For this reason, and in order to be able to reach the remission of the rheumatic condition as soon as possible, the rheumatologists recommend an early intensive treatment with current therapies.
Thus indicates it consensus on biological agents which has produced the Spanish Rheumatology society (be), and updated the guidelines indicated in the last consensus made in 2006.
Rheumatoid arthritis affects already in our country more than 250,000 people, which means that it is suffering around 0.5% of the adult population in Spanish. It’s a progressive inflammatory disease which damaged joints, which makes the patient gradually lose functionality, and therefore see seriously reduced their quality of life.
The most prominent novelties of this consensus indicate that the best treatment for the rheumatic condition is a combination of drug disease (FAME) such as methotrexate – standard therapy for the treatment of rheumatoid arthritis – with biological agents such as the anti-TNF (tumour necrosis factor inhibitors) from the earlier time possible.
On the other hand, this document also indicates that the most optimal result is needed to achieve access to specialized treatment, something that can be achieved through units of rheumatoid arthritis early, put in place by the Spanish society of Rheumatology, and available now in various hospitals.
The objective of addressing the disease from the earliest stages is achieved remission or lesser degree of activity of the same, according to the panel of experts of the being that he has participated in the development of this consensus.
What are biological therapies?
Biological therapies – designed to ensure that they act on a specific therapeutic target – have made a breakthrough in the treatment and control of the progression of rheumatoid arthritis, what he has done that specialists have even changed the therapeutic strategy.
But despite the progress that these new drugs have been, we must bear in mind that still do not get an optimal response in more than 40-50% of patients, that they cease to be effective over time.
On the other hand, due to the first step in the treatment of the disease due do with FAMEs, specialists advise to integrate them into a comprehensive therapeutic strategy of pathology. Thus, this consensus indicates that therapy that more must be taken into account in the treatment of rheumatoid arthritis remain FAMEs as methotrexate and the leflunomida.
Early with anti-TNF treatment
There are currently seven biological agents aimed at the treatment of rheumatoid arthritis, three of them are anti-TNF and four others aimed at specific therapeutic targets with an important role in the disease process. Different studies have shown that the anti – TNF are superior to methotrexate monotherapy and in controlled studies have been makes early treatment with this type of biological agents that it can reach a lasting remission.
Given that there are no data to indicate that an anti-TNF is superior to another, this consensus developed by SER indicates that the three types of drugs are necessary, but not substitutable between themselves, as well as the choice depends on both the criterion of the doctor and the patient’s particular circumstances. Though as they have different structures and mechanisms of action, the lack of response to one of them does not imply that the rest will be ineffective.
This document makes very clear that the use of a biological agent must be accompanied at the outset of a FAME, and will only be used as sole therapy initial in extraordinary cases. In this way, these biological therapies is only administered in monotherapy in patients where this first treatment has failed the therapeutic goal.
Detailed tracking
The use of this type of biological drugs requires, as it indicates this consensus, of a regular assessment of the evolution of the patient, which should be reduced to 3 months if not get the expected objectives or increase to 6 If the evolution is positive.
The consensus places great emphasis on not combine two biological drugs, they are of the type that are. This contraindication is because that increases the risk of the patient to develop infections while there is a clear advantage in its effectiveness.
In the same way, it also insists on not opt for this type of therapy in patients with active infections or with a history of them, as well as those who suffer from tuberculosis or which are in contact with people who suffer from this disease.
Spanish society of Rheumatology (be).
The Spanish Rheumatology society (be) is a scientific association which aims to promote the study of rheumatic diseases – diseases of the musculoskeletal system and connective tissue – for the benefit of patients and to address problems related to the specialty. SER currently represents nearly 1,500 professionals in Spain and maintains contact with regional societies of Rheumatology from across the country. SER develops work, studies and research projects in rheumatology by the Spanish Foundation of Rheumatology (FER) and provides support to patients of rheumatic diseases through his relationship with associations comprising mainly patients as the LIRE (Rheumatology Spanish League)CONFEPAR (Confederation of patients Reumáticos), ConArtritis (national coordinator of arthritis) or the Spanish Forum of patients.
Read More